JPS56156289A - Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone - Google Patents

Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone

Info

Publication number
JPS56156289A
JPS56156289A JP5189881A JP5189881A JPS56156289A JP S56156289 A JPS56156289 A JP S56156289A JP 5189881 A JP5189881 A JP 5189881A JP 5189881 A JP5189881 A JP 5189881A JP S56156289 A JPS56156289 A JP S56156289A
Authority
JP
Japan
Prior art keywords
bis
dihydroxyanthraquinone
substituted amino
metal chelate
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5189881A
Other languages
English (en)
Other versions
JPH0255438B2 (ja
Inventor
Arubaato Rangu Jiyuni Sutanrei
Chiyadouitsuku Murudotsu Keito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of JPS56156289A publication Critical patent/JPS56156289A/ja
Publication of JPH0255438B2 publication Critical patent/JPH0255438B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP5189881A 1980-04-09 1981-04-08 Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone Granted JPS56156289A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/138,620 US4296030A (en) 1980-04-09 1980-04-09 Metal chelates of 1,4-bis(substituted-amino-5,8-dihydroxy-anthraquinones

Publications (2)

Publication Number Publication Date
JPS56156289A true JPS56156289A (en) 1981-12-02
JPH0255438B2 JPH0255438B2 (ja) 1990-11-27

Family

ID=22482851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5189881A Granted JPS56156289A (en) 1980-04-09 1981-04-08 Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone

Country Status (5)

Country Link
US (1) US4296030A (ja)
EP (1) EP0037486B1 (ja)
JP (1) JPS56156289A (ja)
AT (1) ATE5960T1 (ja)
DE (1) DE3162004D1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6169783A (ja) * 1984-08-03 1986-04-10 ベ−リンガ−・マンハイム・イタリア・ソシエタ・ペル・アチオニ シス−白金錯体、その製法、およびそれを含有する抗腫瘍剤

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820738A (en) * 1977-08-15 1989-04-11 American Cyanamid Company 1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4456552A (en) * 1979-08-02 1984-06-26 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4614618A (en) * 1979-08-02 1986-09-30 American Cyanamid Company 1,4-bis(substituted-amino)-5,8-dihydroxy anthraquinones and leuco bases thereof
US4366312A (en) * 1980-03-13 1982-12-28 Ciba-Geigy Corporation Metal complexes of isoindolinazines, process for their preparation and use
US4515954A (en) * 1981-08-24 1985-05-07 American Cyanamid Company Metal chelates of anthracene-9,10-bis-carbonylhydrazones
EP0083683A1 (en) * 1981-10-26 1983-07-20 American Cyanamid Company Method of preparing 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and pharmaceutical compositions containing them
EP0085760A3 (en) * 1982-02-04 1984-07-04 American Cyanamid Company Novel 1-4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4715993A (en) * 1983-03-18 1987-12-29 American Cyanamid Company Process for preparing certain 1,4-di[ω-(2-hydroxyethylamino)alkylamino]anthraquinone free bases
US4540788A (en) * 1983-07-14 1985-09-10 American Cyanamid Company Schiff bases of [(aminoalkyl or substituted aminoalkyl)amino]-9,10-anthracenediones
IL76002A0 (en) * 1984-08-03 1985-12-31 Boehringer Biochemia Srl Amino-anthracenediones-platinum complexes useful as anti-cancer compounds
EP0182135A3 (en) * 1984-11-19 1987-08-05 American Cyanamid Company Novel bis-(substituted amino) anthraquinones
US4732970A (en) * 1986-06-13 1988-03-22 American Cyanamid Company Antitumor amino acid and peptide derivatives of 1,4-bis(aminoalkyl and hydroxy-aminoalkyl)amino)-5,8-dihydroxyanthraquinones
WO1989005815A1 (en) * 1987-12-18 1989-06-29 Boehringer Biochemia Robin S.P.A. Amino anthracenediones-bis platinum complexes, useful as antitumoral agents
DE3923270A1 (de) * 1989-07-14 1991-01-17 Medac Klinische Spezialpraep Wasserloesliche pharmazeutische metallocen-komplex-zusammensetzung
US5604095A (en) * 1994-07-22 1997-02-18 Cancer Therapy & Research Center Unsymmetrically linked bisnaphthalimides as antitumor agents
US5561042A (en) * 1994-07-22 1996-10-01 Cancer Therapy And Research Center Diamine platinum naphthalimide complexes as antitumor agents
JP2000502988A (ja) * 1995-08-18 2000-03-14 オークランド ユニサーヴィスィズ リミテッド 放射線活性化サイトトキシン療法
CN103641852B (zh) * 2013-12-04 2017-04-12 西安近代化学研究所 1,4,5,8‑四羟基蒽醌铅化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA736976A (en) * 1966-06-21 A. Cascardo Charles Complex metal anthraquinone dyestuffs
US2301286A (en) * 1937-12-20 1942-11-10 Chem Ind Basel Process of making an n n' dianthraquinonyl naphthalenediamine
US2626255A (en) * 1950-03-15 1953-01-20 Nat Lead Co Zirconium pigments
US4141992A (en) * 1975-08-22 1979-02-27 American Cyanamid Company Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents
US4197249A (en) * 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
SE445996B (sv) * 1977-08-15 1986-08-04 American Cyanamid Co Nya atrakinonderivat

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6169783A (ja) * 1984-08-03 1986-04-10 ベ−リンガ−・マンハイム・イタリア・ソシエタ・ペル・アチオニ シス−白金錯体、その製法、およびそれを含有する抗腫瘍剤

Also Published As

Publication number Publication date
EP0037486A3 (en) 1981-10-21
JPH0255438B2 (ja) 1990-11-27
US4296030A (en) 1981-10-20
ATE5960T1 (de) 1984-02-15
DE3162004D1 (en) 1984-03-01
EP0037486A2 (en) 1981-10-14
EP0037486B1 (en) 1984-01-25

Similar Documents

Publication Publication Date Title
JPS56156289A (en) Metal chelate of 1,4-bis(substituted amino)- 5,8-dihydroxyanthraquinone
ES8206440A1 (es) Un procedimiento para la preparacion del enantiomero (-) de la n-metil-3-(2metilfenoxi)-3-fenilpropilamina.
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
GB1385059A (en) Substituted p-phenylenediamines
TW218869B (ja)
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
MY102705A (en) Proline derivaties and related compounds.
JPS5412381A (en) N-alkylpiperidine derivative
ES520340A0 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas.
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
PT97353A (pt) Processo para a preparacao de uma composicao pigmentar anticorrosiva contendo hidroxi-8-quinoleato de zinco,destinada a revestimentos
GB2120244B (en) Aminoalkadiene derivative
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
IE32975L (en) Isoindole derivatives
GB1518042A (en) Oxadiazolinone derivatives
EP0085760A3 (en) Novel 1-4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
BG35041A3 (en) Method for preparing substituted 2- piperadine- 4- amino- 6, 7- dimetoxyquinazolines
GB1526172A (en) Antihypertensive compositions
HK1024872A1 (en) Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
GB1422480A (en) Ammonium cinnemates and their use as light-screening agents
BG43005A3 (en) Method for preparing condensed as- triazines
JPS5414955A (en) 1-aminomethyltricyclo(4,3,1,12,5)undecane and acid adduct
SU803383A1 (ru) Гидрохлорид 3,3,6-триметил-1,2,3,4-тетрагидроиндоло/2,3-с/хинолина, обладающий антидепрессантной активностью